Premium
Balanced nutrient fortification enables high‐density hybridoma cell culture in batch culture
Author(s) -
Jo EuiCheol,
Park HaeJoon,
Park JongMyun,
Kim KyongHo
Publication year - 1990
Publication title -
biotechnology and bioengineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 189
eISSN - 1097-0290
pISSN - 0006-3592
DOI - 10.1002/bit.260360709
Subject(s) - cell culture , in vitro , glutamine , chemically defined medium , in vivo , biology , biochemistry , nutrient , monoclonal antibody , cell growth , ammonium , chemistry , amino acid , antibody , microbiology and biotechnology , immunology , ecology , genetics , organic chemistry
Cells of an in vitro culture system are not the same as for an in vivo system, metabolically and physiologically; ineffective utilization of nutrients occurs by cells in vitro. Therefore, a simpler approach is needed to examine closely and overcome differences between in vivo and in vitro cells. Recognizing the ineffectiveness of nutrient utilization in vitro, we have constructed, a balanced, fortified high‐density medium based on RPMI 1640 medium previously optimized for relatively low‐density cell culture. The high‐density medium was used to cultivate a hybridoma line in a batch spinner flask culture. In this fortified medium, a hybridoma cell line 2c3.1 was cultivated to near 1 × 10 7 cells/mL in batch suspension culture. During the culture, glucose, glutamine, and 10 essential amino acids of concentrations five times richer than normal in the medium were almost thoroughly consumed. Combined analysis of these consumption profiles reveals that the balanced, fortified nutrient supply contributes much to cellular activity to overcome the limitations of in vitro cellular growth. Intermediate metabolites, such as ammonium ion and lactic acid, were produced over concentrations reported until now to be inhibitory. This observation suggests that the major conclusive factor against cellular growth over the critical cell density is not so‐called inhibitory metabolites. As a result of the high‐density culture, 5–8 times higher production of a monoclonal antibody for hepatitis B surface antigen (anti‐HBs) was obtained. Active cellular consumption of all the essential nutrients and the corresponding production of MAb strongly support the potential of our approach to overcome the growth limitation of cells in vitro and to obtain high‐density hybridoma cell culture.